Navigation Links
Women cautioned against using herbal supplements

health problems. Yet, there is no focused safety testing of herbal medicines or even reporting system for adverse effects, so when people do have adverse effects, there's no mechanism to pool that data."

Warren said that researchers used to think that estrogen-like compounds from plants, called phytoestrogens, could possibly block the effect of estrogen in the body and perhaps reduce breast cancer risk. However, recent clinical studies have shown that women on diets high in soy phytoestrogens experience greater cell multiplication in the breast. There is concern over this effect since it could be a preliminary step in cancer formation by leading to the outgrowth of latent cancer cells.

In looking at studies on the use of supplements for menopause, Warren reports that the seven clinical trials using black cohosh were largely flawed but might suggest some effectiveness. However, little evidence exists for beneficial effects of red clover, and no benefit was reported for ginseng, evening primrose oil or dong quai. In the 16 studies that looked at soy supplements, twice as many studies reported no effect as those that reported a beneficial effect, and although kava kava has been reported to have some benefit, reports of serious side effects have led to it being banned for sale in the United States and elsewhere.

For premenstrual syndrome, several studies found some benefit in about half the women studied for evening primrose oil, but two of the best designed studies found no effect; ginkgo biloba extract was found to have no effect, while a beneficial response from chaste tree berry extracts was found in about half the women studied. For menstrual pain, two clinical trials have examined the Japanese herbal preparations toki-shakuyakusan and toki-shakuyakusan with shakuyaku-kanzoto; neither found a beneficial effect.

"Some herbal medicines show promise for the treatment of problems with menstruation and menopause and other conditions that
'"/>

Source:Cornell University News Service


Page: 1 2 3

Related biology news :

1. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
2. Women feel more pain than men, research shows
3. Womans Day and For Womens of Science
4. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
5. Bound for destruction: Ubiquitination protects against improper Notch signaling
6. Female sex hormones play a vital role in defense against sexually transmitted diseases
7. In the sea slugs defense against lobsters, confusion is key
8. Antibodies from plants protect against anthrax
9. Molecular models advance the fight against malaria
10. Sickle cell and protection against malaria
11. Live vaccines more effective against horse herpes virus
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women cautioned against using herbal supplements

(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
(Date:2/5/2015)... 27, 2015   Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... at the University of Cincinnati (UC) have found a ... to therapies to prevent the development of the nation,s ... findings will be presented for the first time at ... Nov. 17. The study, led by WenFeng Cai, ...
... a drug already approved for treating multiple sclerosis show ... bioterrorist attack with botulinum neurotoxin which is 10,000 ... known to man. The potential drugs also could be ... well as Alzheimer,s disease, multiple sclerosis, and myasthenia gravis, ...
... presented at the 2010 FIP Pharmaceutical Sciences World Congress ... Annual Meeting and Exposition will highlight a targeted inhalable ... of needle avoidance and expected lower cost than the ... world. HPV is the number one ...
Cached Biology News:Researchers discover potential genetic target for heart disease 2New needle-free HPV vaccine increases effectiveness, availability in developing world 2
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading personal ... Black as Privacy Officer and Corporate Counsel. Black ... privacy laws as well as health care regulations. As ... will be responsible for reviewing, updating and enhancing the ... U.S. and abroad. She joined the company January 5, ...
(Date:2/26/2015)... 26, 2015   Regulus Therapeutics Inc . (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, today ... and Chief Executive Officer of Regulus, will present a ... Annual Healthcare Conference on Wednesday, March 4, 2015 ... at the Boston Marriott Copley Place.  ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The Movement ... demonstration to support life extension technologies and awareness. The ... Universal Coordinated Time, on March 21st 2015, in a ... , Eric Schulke, Founder of MILE, says, “Our ... with urgency. The Movement for Indefinite Life Extension is ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 423andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3
... Conn., March 29, 2011 USChina Channel LLC announced today: ... Commonwealth Biotechnologies Inc. ("CBI") filed Form 8-k of SEC, to ... The vote process is going very well. We ... stock made the vote. Followings are the interim vote results ...
... March 29, 2011 AMDeC, LLC ... Program to include products offered by Sigma® Life ... of Sigma-Aldrich® (Nasdaq: SIAL).  AMDeC is a consortium ... New York region that is focused on increasing ...
... (OTC Bulletin Board: SNGX ) (Soligenix or ... financial results for the year ended December 31, 2010. ... December 31, 2010 were $1,947,628 as compared to $2,816,037 ... or 31%.  During 2009, Soligenix received a $1 million ...
Cached Biology Technology:Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information 2Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information 3Sigma® Life Science Joins AMDeC's Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers 2Sigma® Life Science Joins AMDeC's Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers 3Sigma® Life Science Joins AMDeC's Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers 4Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 2Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 3Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 4Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 5
Mouse monoclonal [HL-37] to HLA DQ1 + HLA DQ3 ( Abpromise for all tested applications)....
SHEEP ANTI BOVINE BETA-LACTOGLOBULIN A...
... Convenient platform for tube handling and reagent dispensing ... V-bottom tubes - 96 x 0.3ml ... - Thermo-Fast® 96 Non-Skirted Plate ... 48 x 0.5ml Thermo-Tubes Multiple workstations can be securely ...
6B9...
Biology Products: